"CZ - \u010Cesk\u00E1 republika" . "Budinsk\u00E1, Eva" . "S" . "\u010Cesk\u00E1 radiologie" . "4"^^ . "Foukal, Jakub" . . . . . . "1210-7883" . . "\u0160mardov\u00E1, Lenka" . "Contrast-enhanced ultrasound in differential diagnosis of lymphadenopathy - first experiences"@en . "Contrast-enhanced ultrasound in differential diagnosis of lymphadenopathy - first experiences"@en . . "RIV/00216224:14110/09:00051161!RIV12-MSM-14110___" . "RIV/00216224:14110/09:00051161" . "Vyu\u017Eit\u00ED kontrastn\u00EDho ultrazvukov\u00E9ho vy\u0161et\u0159en\u00ED v diferenci\u00E1ln\u00ED diagnostice lymfadenopati\u00ED - prvn\u00ED zku\u0161enosti"@cs . "Vyu\u017Eit\u00ED kontrastn\u00EDho ultrazvukov\u00E9ho vy\u0161et\u0159en\u00ED v diferenci\u00E1ln\u00ED diagnostice lymfadenopati\u00ED - prvn\u00ED zku\u0161enosti"@cs . . "Aim. The aim of our study was to evaluate the benefit of contrast-enhanced ultrasound in distinction between benign and malignant lymphadenopathy in patients with cervical, axillary and inguinal lymphadenopathy. Method. From January to September 2008 total number of 48 patients (14 women, 34 men) between the ages of 22-86 years with suspicion of peripheral lymphadenopathy underwent ultrasound examination. All patients were examined with Philips iU22 ultrasound machine, using 17 MHz probe for native exam and 9 MHz probe with intravenous bolus of 1,5 ml sulphur hexafluoride contrast agent. After lymph nodes? exstirpation ultrasound and histological fi ndings were corelated. Results. According to results of ROC analysis contrast-enhanced ultrasound (CEUS) has high total accuracy (88,9%). Sensitivity in comparison with native ultrasound examination increased from 67,7 to 100% and specificity increased from 66,7 to 77,8%."@en . "\u0160laisov\u00E1, Radka" . "8"^^ . . . . . "Vyu\u017Eit\u00ED kontrastn\u00EDho ultrazvukov\u00E9ho vy\u0161et\u0159en\u00ED v diferenci\u00E1ln\u00ED diagnostice lymfadenopati\u00ED - prvn\u00ED zku\u0161enosti" . "[8167FB936D5C]" . "1" . . "Vyu\u017Eit\u00ED kontrastn\u00EDho ultrazvukov\u00E9ho vy\u0161et\u0159en\u00ED v diferenci\u00E1ln\u00ED diagnostice lymfadenopati\u00ED - prvn\u00ED zku\u0161enosti" . . . "63" . "14110" . "C\u00EDl. C\u00EDlem pr\u00E1ce bylo u skupiny pacient\u016F s cervik\u00E1ln\u00ED, axil\u00E1rn\u00ED a inguin\u00E1ln\u00ED lymfadenopati\u00ED zjistit p\u0159\u00EDnos pou\u017Eit\u00ED kontrastn\u00ED ultrazvukov\u00E9 l\u00E1tky p\u0159i rozli\u0161en\u00ED mezi benign\u00ED a malign\u00ED etiologi\u00ED lymfadenopatie. Metoda. Od ledna do z\u00E1\u0159\u00ED 2008 bylo pro klinick\u00E9 podez\u0159en\u00ED na perifern\u00ED lymfadenopatii vy\u0161et\u0159eno celkem 48 pacient\u016F (14 \u017Een, 34 mu\u017E\u016F) ve v\u011Bku 22-86 let, u kter\u00FDch bylo exstirpov\u00E1no celkem 52 uzlin. V\u0161ichni pacienti byli vy\u0161et\u0159eni na ultrazvukov\u00E9m p\u0159\u00EDstroji Philips iU22 17 MHz sondou nativn\u011B a 9 MHz sondou po intraven\u00F3zn\u00ED aplikaci 1,5 ml hexafluoridu s\u00EDrov\u00E9ho. Po n\u00E1sledn\u00E9 exstirpaci uzliny byly ultrazvukov\u00E9 n\u00E1lezy vyhodnoceny v korelaci s n\u00E1lezy histologick\u00FDmi. V\u00FDsledky. Podle v\u00FDsledk\u016F ROC anal\u00FDzy vykazuje metoda kontrastn\u00EDho ultrazvukov\u00E9ho vy\u0161et\u0159en\u00ED (CEUS) vysokou celkovou p\u0159esnost (88,9 %). Senzitivita oproti nativn\u00EDmu vy\u0161et\u0159en\u00ED vzrostla o 32,3 % (celkov\u011B 100%), specificita vzrostla o 11,1 % (celkov\u011B 77,8%)."@cs . "sulphur hexafluoride; contrast-enhanced ultrasound; lymphadenopathy"@en . "C\u00EDl. C\u00EDlem pr\u00E1ce bylo u skupiny pacient\u016F s cervik\u00E1ln\u00ED, axil\u00E1rn\u00ED a inguin\u00E1ln\u00ED lymfadenopati\u00ED zjistit p\u0159\u00EDnos pou\u017Eit\u00ED kontrastn\u00ED ultrazvukov\u00E9 l\u00E1tky p\u0159i rozli\u0161en\u00ED mezi benign\u00ED a malign\u00ED etiologi\u00ED lymfadenopatie. Metoda. Od ledna do z\u00E1\u0159\u00ED 2008 bylo pro klinick\u00E9 podez\u0159en\u00ED na perifern\u00ED lymfadenopatii vy\u0161et\u0159eno celkem 48 pacient\u016F (14 \u017Een, 34 mu\u017E\u016F) ve v\u011Bku 22-86 let, u kter\u00FDch bylo exstirpov\u00E1no celkem 52 uzlin. V\u0161ichni pacienti byli vy\u0161et\u0159eni na ultrazvukov\u00E9m p\u0159\u00EDstroji Philips iU22 17 MHz sondou nativn\u011B a 9 MHz sondou po intraven\u00F3zn\u00ED aplikaci 1,5 ml hexafluoridu s\u00EDrov\u00E9ho. Po n\u00E1sledn\u00E9 exstirpaci uzliny byly ultrazvukov\u00E9 n\u00E1lezy vyhodnoceny v korelaci s n\u00E1lezy histologick\u00FDmi. V\u00FDsledky. Podle v\u00FDsledk\u016F ROC anal\u00FDzy vykazuje metoda kontrastn\u00EDho ultrazvukov\u00E9ho vy\u0161et\u0159en\u00ED (CEUS) vysokou celkovou p\u0159esnost (88,9 %). Senzitivita oproti nativn\u00EDmu vy\u0161et\u0159en\u00ED vzrostla o 32,3 % (celkov\u011B 100%), specificita vzrostla o 11,1 % (celkov\u011B 77,8%)." . . "4"^^ . "350835" . .